Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04797052
Other study ID # 20.377
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 5, 2021
Est. completion date January 30, 2023

Study information

Verified date March 2023
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

VEEGix is a portable device developed by NeuroServo for simplifying electroencephalograms at the bedside. It is an easy-to-use device that only requires the operator to place an adhesive strip of electrodes on the patient's forehead, connected to the device. The goal of this study is to determine EEG thresholds for the diagnostic of delirium. Methods : This prospective observational study includes patients undergoing orthopedic or degestive surgery. Each subject will have an EEG reading before surgery and twice daily after surgery until discharge or up to 5 days. Patients will be monitored for post operative delirium using the 3D-Confusion Assessment Method. Delirium diagnostic will be confirmed by a geriatrician. EEG relative power reading will be compared between patient with and without a delirium diagnostic.


Recruitment information / eligibility

Status Completed
Enrollment 234
Est. completion date January 30, 2023
Est. primary completion date January 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 120 Years
Eligibility Inclusion Criteria: - 65 years and older - Had a orthopedic or digestive surgery - Good undersanding of French or English - Consent to participate in the study Exclusion Criteria: - History of seizure or epilepsia - Structural brain damage - intelectual deiciency - Severe major neurocognitive disorder - incapacity to respond to the questionnaire - Hospitalised in intensive care or intubated

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Prefrontal EEG (VEEGix by NeuroServo)
Prefrontal EEG reading

Locations

Country Name City State
Canada Centre Hospitalier de l'Université de Montréal Montreal Quebec

Sponsors (2)

Lead Sponsor Collaborator
Centre hospitalier de l'Université de Montréal (CHUM) TransMedTech Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference of relative power of delta and theta brain waves Difference between group with and without delirium up to five days after the operation
Secondary Difference of relative power of beta and alpha brain waves Difference between group with and without delirium up to five days after the operation
Secondary describe the presence of artefacts Examine the EEG reading for artefacts up to five days after the operation
See also
  Status Clinical Trial Phase
Completed NCT02213380 - Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery N/A
Recruiting NCT06355570 - Delirium After Cardiac Surgery in Intensive Care Units N/A
Recruiting NCT05242419 - A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery N/A
Recruiting NCT05765162 - Safe Brain Initiative, Operationalizing Precision Anaesthesia
Not yet recruiting NCT05949229 - The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery. Phase 1/Phase 2